Gastric Neoplasm Risk with DPP-4 Inhibitors, GLP-1 Receptor Agonists, and SGLT2 Inhibitors: Network Meta-Analysis of Randomized Trials. - Hung CM; Hsu CW; Zeng BS; Suen MW; Chen JJ; Zeng BY; Carvalho AF; Stubbs B; Chen YW; Chen TY; Hsu SP; Wang HY; et al. (International journal of molecular sciences, 2026)